State Street Corp Ac Immune Sa Transaction History

State Street Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.85 - $3.4 $5,381 - $9,890	-2,909 Reduced 4.91%	56,369 $166,000
Q1 2023 May 15, 2023	SELL	$2.13 - $2.49 $536 - $627	-252 Reduced 0.42%	59,278 $138,000
Q4 2022 Feb 14, 2023	BUY	$1.72 - $3.12 $438 - $795	255 Added 0.43%	59,530 $121,000
Q3 2022 Nov 15, 2022	BUY	$2.4 - $3.64 $2,433 - $3,690	1,014 Added 1.74%	59,275 $187,000
Q2 2022 Aug 15, 2022	SELL	$2.35 - $4.47 $1,191 - $2,266	-507 Reduced 0.86%	58,261 $210,000
Q1 2022 May 16, 2022	BUY	$3.5 - $5.16 $8,855 - $13,054	2,530 Added 4.5%	58,768 $235,000
Q4 2021 Feb 14, 2022	BUY	$4.83 - $7.56 $4,830 - $7,560	1,000 Added 1.81%	56,238 $278,000
Q3 2021 Nov 15, 2021	BUY	$6.2 - $8.34 $170,679 - $229,591	27,529 Added 99.35%	55,238 $371,000
Q2 2021 Aug 16, 2021	SELL	$6.04 - $8.37 $3,654 - $5,063	-605 Reduced 2.14%	27,709 $220,000
Q4 2020 Feb 16, 2021	SELL	$4.47 - $5.58 $3,786 - $4,726	-847 Reduced 2.9%	28,314 $146,000
Q3 2020 Nov 10, 2020	SELL	$4.78 - $9.06 $5,162 - $9,784	-1,080 Reduced 3.57%	29,161 $142,000
Q2 2020 Aug 14, 2020	BUY	$6.57 - $8.3 $2,943 - $3,718	448 Added 1.5%	30,241 $204,000
Q1 2020 May 11, 2020	BUY	$4.24 - $9.89 $126,322 - $294,652	29,793 New	29,793 $206,000

28.6M

163K

37.6K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $309M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.